Evidence map›Paper›PMID 37809033›Full record

ArticleCrohn's & colitis 3602023

Bedside Intestinal Ultrasound Performed in an Inflammatory Bowel Disease Urgent Assessment Clinic Improves Clinical Decision-Making and Resource Utilization.

Joëlle St-Pierre, Maxime Delisle, Hengameh Kheirkhahrahimabadi, Thomas M Goodsall, Robert V Bryant, Britt Christensen, Rose Vaughan, Aysha Al-Ani, Richard J M Ingram, Joan Heatherington and 4 more

Abstract read
In one paragraph

Article in Crohn's & colitis 360, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Joëlle St-PierreIBD Unit, Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0002-7393-4950
Maxime DelisleIBD Unit, Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0003-0100-3898
Hengameh KheirkhahrahimabadiDivision of Rheumatology, Department of Medicine, University of Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0001-7974-7809
Thomas M GoodsallIBD Service, Department of Gastroenterology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.ORCID https://orcid.org/0000-0002-4659-2422
Robert V BryantIBD Service, Department of Gastroenterology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.ORCID https://orcid.org/0000-0003-4229-3289
Britt ChristensenDepartment of Gastroenterology, The Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-8746-4275
Rose VaughanDepartment of Gastroenterology, The Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0001-7534-1203
Aysha Al-AniDepartment of Gastroenterology, The Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-4735-5234
Richard J M IngramIBD Unit, Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Alberta, Canada.
Joan HeatheringtonIBD Unit, Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Alberta, Canada.
Dan CarterDepartment of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID https://orcid.org/0000-0001-7979-6803
Cathy LuIBD Unit, Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0003-3004-7048
Christopher MaIBD Unit, Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0002-4698-9948
Kerri L NovakIBD Unit, Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0003-4164-7321

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with inflammatory bowel disease (IBD) require accessible, timely, and noninvasive strategies to monitor disease. The aim was to assess the integration of intestinal ultrasound (IUS) on decision-making and endoscopy utilization in a standardized care pathway. Methods: This prospective, multicenter, international, observational cohort study included patients seen within a centralized model for IBD care was conducted during the COVID pandemic. Patients were evaluated with IUS alone or in combination with an in-clinic, unsedated sigmoidoscopy. Demographic, clinical, laboratory, and imaging data, clinical decisions, and need for urgent endoscopy, hospitalization, and surgeries were recorded. Results: Of the 158 patients included, the majority had an established diagnosis of Crohn's disease ( Conclusions: Point-of-care IUS used in a flare clinic pathway is a useful strategy to improve effective IBD care delivery and to assist in therapeutic management decisions, in many cases avoiding the acute need for endoscopy.

Indexed as

COVID-19Crohn’s diseaseinflammatory bowel diseaseintestinal ultrasoundpoint-of-care ultrasoundulcerative colitis

Identifiers

PMID37809033
PMCPMC10558199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.